Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
专家展望：5位分析师眼中的Mersana Therapeutics
Ratings for Mersana Therapeutics (NASDAQ:MRSN) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，有5位分析师提供了Mersana Therapeutics（纳斯达克股票代码：MRSN）的评级，显示了看涨和看跌的观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Mersana Therapeutics, presenting an average target of $6.6, a high estimate of $9.00, and a low estimate of $5.00. This upward trend is apparent, with the current average reflecting a 103.08% increase from the previous average price target of $3.25.
在评估12个月目标股价时，分析师公布了对Mersana Therapeutics的见解，将平均目标股价定为6.6美元，最高估计为9.00美元，低估值为5.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标价3.25美元上涨了103.08％。
Breaking Down Analyst Ratings: A Detailed Examination...
分解分析师评级...
登录免费看全文
登录/注册